Methylphenidate Teva Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

The following table shows all adverse reactions observed during clinical trials of children, adolescents, and adults and post-market spontaneous reports with Methylphenidate Teva and those which have been reported with other methylphenidate hydrochloride formulations. If the adverse reactions with Methylphenidate Teva and the methylphenidate formulation frequencies were different, the highest frequency of both databases was used. (See Tables 2a and 2b.)
Frequency estimate: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100); rare (≥1/10,000 to <1/1000); very rare (<1/10,000); not known (cannot be estimated from the available data).

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

View ADR Monitoring Form

Methylphenidate Teva Adverse Reactions

methylphenidate

Manufacturer:

Teva

Distributor:

Zuellig